Referral Approaches for Tobacco Use
Trial Summary
What is the purpose of this trial?
The investigators propose a Type I hybrid effectiveness/implementation study to evaluate two population-based approaches for increasing use of Quitlines and text messaging at two VA sites. Specifically, the investigators will test the default bias, examining whether an opt-out approach to referral is more effective than an opt-in approach. The investigators will randomly assign teams to either an opt-out or opt-in approach to referring smokers to treatment. In the opt-out approach, the default is that everyone is referred to treatment unless they actively choose not to be. In the opt-in approach, people are offered treatment but must actively choose to enroll in it.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on smoking cessation methods, so it's best to ask the trial coordinators for more details.
What data supports the effectiveness of the treatment involving staff training and academic detailing for tobacco use?
Research shows that healthcare providers can play a crucial role in helping people quit smoking by using evidence-based treatments like counseling and follow-up. However, there are gaps in the guidance provided to them, suggesting that better training and detailed information could improve their effectiveness in supporting tobacco cessation.12345
Is the referral approach for tobacco use treatment safe for humans?
How does the treatment in the Referral Approaches for Tobacco Use trial differ from other treatments for tobacco use?
This treatment is unique because it focuses on referral approaches, which may involve directing patients to specialized programs or resources for tobacco cessation, rather than solely relying on direct counseling or medication. This approach can help overcome barriers to accessing effective tobacco cessation support, making it different from traditional methods that primarily focus on direct interventions.1112131415
Research Team
Steven S. Fu, MD MSCE
Principal Investigator
Minneapolis VA Health Care System, Minneapolis, MN
Scott E. Sherman, MD MPH
Principal Investigator
VA NY Harbor Healthcare System, New York, NY
Eligibility Criteria
This trial is for current smokers who have been seen by a nursing assistant on the PACT team at the Manhattan or Brooklyn VA campus within the last year. It's also open to those nurses and administrative staff who smoke. Non-English speakers cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants are randomly assigned to either an opt-out or opt-in approach for smoking cessation treatment referral
Follow-up
Participants are monitored for smoking cessation outcomes and cost-effectiveness of the approaches
Treatment Details
Interventions
- Staff training and academic detailing
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor